Posted February 2005
Bolten, B.M. and DeGregorio, T. (2002) Trends in development cycles. Nature Reviews
Drug Discovery 1, 335-336.
Chanda, S.K. and Caldwell, J.S. (2003) Fulfilling the promise: drug discovery in
the post-genomic area. Drug Discovery Today 8, 168-174.
DiMasi, J.A., Hansen, R.W. and Grabowski, H.G. (2003) The price of innovation: new
estimates of drug development costs. J. Health Economics 22, 151-185.
Drews, J. (2000) Drug Discovery: a historical perspective. Science 287, 1960-1964.
FDA (2004) Innovation and Stagnation: Challenge and Opportunity on the Critical
Path to New Medical Products. FDA White Paper.
Handen, J.S. (2002) The industrialization of drug discovery. Drug Discovery Today
Kola, I. And Landis, J. (2004) Can the pharmaceutical industry reduce attrition
rates? Nature Reviews Drug Discovery 3, 711-715.
Lindsay, M.A. (2003) Target discovery. Nature Reviews Drug Discovery 2, 831-838.
Nature Insight: Chemical Space (2004) Nature 432, 824-865.
Sams-Dodd, Frank (2005) Target-based drug discovery: is something wrong? Drug Discovery
Today 10, 139-147.
Related Web Sites
FDA Center for Drug Evaluation and Research
Tufts Center for the Study of Drug Development